296 related articles for article (PubMed ID: 10725724)
1. Novel mutations within the RFX-B gene and partial rescue of MHC and related genes through exogenous class II transactivator in RFX-B-deficient cells.
Nagarajan UM; Peijnenburg A; Gobin SJ; Boss JM; van den elsen PJ
J Immunol; 2000 Apr; 164(7):3666-74. PubMed ID: 10725724
[TBL] [Abstract][Full Text] [Related]
2. Discoordinate expression of invariant chain and MHC class II genes in class II transactivator-transfected fibroblasts defective for RFX5.
Peijnenburg A; Van Eggermond MJ; Gobin SJ; Van den Berg R; Godthelp BC; Vossen JM; Van den Elsen PJ
J Immunol; 1999 Jul; 163(2):794-801. PubMed ID: 10395672
[TBL] [Abstract][Full Text] [Related]
3. Conserved residues of the bare lymphocyte syndrome transcription factor RFXAP determine coordinate MHC class II expression.
Long AB; Ferguson AM; Majumder P; Nagarajan UM; Boss JM
Mol Immunol; 2006 Feb; 43(5):395-409. PubMed ID: 16337482
[TBL] [Abstract][Full Text] [Related]
4. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients.
Masternak K; Barras E; Zufferey M; Conrad B; Corthals G; Aebersold R; Sanchez JC; Hochstrasser DF; Mach B; Reith W
Nat Genet; 1998 Nov; 20(3):273-7. PubMed ID: 9806546
[TBL] [Abstract][Full Text] [Related]
5. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
[TBL] [Abstract][Full Text] [Related]
6. The RFX complex is crucial for the constitutive and CIITA-mediated transactivation of MHC class I and beta2-microglobulin genes.
Gobin SJ; Peijnenburg A; van Eggermond M; van Zutphen M; van den Berg R; van den Elsen PJ
Immunity; 1998 Oct; 9(4):531-41. PubMed ID: 9806639
[TBL] [Abstract][Full Text] [Related]
7. The transcription factor RFX protects MHC class II genes against epigenetic silencing by DNA methylation.
Seguín-Estévez Q; De Palma R; Krawczyk M; Leimgruber E; Villard J; Picard C; Tagliamacco A; Abbate G; Gorski J; Nocera A; Reith W
J Immunol; 2009 Aug; 183(4):2545-53. PubMed ID: 19620312
[TBL] [Abstract][Full Text] [Related]
8. Associations and interactions between bare lymphocyte syndrome factors.
DeSandro AM; Nagarajan UM; Boss JM
Mol Cell Biol; 2000 Sep; 20(17):6587-99. PubMed ID: 10938133
[TBL] [Abstract][Full Text] [Related]
9. Two newly diagnosed HLA class II-deficient patients identified by rapid vector-based complementation analysis reveal discoordinate invariant chain expression levels.
Schmetterer KG; Seidel MG; Körmöczi U; Rottal A; Schwarz K; Matthes-Martin S; Steinberger P; Pickl WF
Int Arch Allergy Immunol; 2010; 152(4):390-400. PubMed ID: 20197681
[TBL] [Abstract][Full Text] [Related]
10. Mutation in the class II trans-activator leading to a mild immunodeficiency.
Wiszniewski W; Fondaneche MC; Le Deist F; Kanariou M; Selz F; Brousse N; Steimle V; Barbieri G; Alcaide-Loridan C; Charron D; Fischer A; Lisowska-Grospierre B
J Immunol; 2001 Aug; 167(3):1787-94. PubMed ID: 11466404
[TBL] [Abstract][Full Text] [Related]
11. The bare lymphocyte syndrome and the regulation of MHC expression.
Reith W; Mach B
Annu Rev Immunol; 2001; 19():331-73. PubMed ID: 11244040
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of G1B and G3A IFN gamma mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction.
Chin KC; Mao C; Skinner C; Riley JL; Wright KL; Moreno CS; Stark GR; Boss JM; Ting JP
Immunity; 1994 Nov; 1(8):687-97. PubMed ID: 7600294
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the defect in IFN-gamma induction of MHC class II genes in G1B cells: identification of a novel and functionally critical leucine-rich motif (62-LYLYLQL-68) in the regulatory factor X 5 transcription factor.
Brickey WJ; Wright KL; Zhu XS; Ting JP
J Immunol; 1999 Dec; 163(12):6622-30. PubMed ID: 10586057
[TBL] [Abstract][Full Text] [Related]
14. Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation.
Masternak K; Reith W
EMBO J; 2002 Mar; 21(6):1379-88. PubMed ID: 11889043
[TBL] [Abstract][Full Text] [Related]
15. CIITA-induced occupation of MHC class II promoters is independent of the cooperative stabilization of the promoter-bound multi-protein complexes.
Villard J; Muhlethaler-Mottet A; Bontron S; Mach B; Reith W
Int Immunol; 1999 Mar; 11(3):461-9. PubMed ID: 10221658
[TBL] [Abstract][Full Text] [Related]
16. Identification of class II transcriptional activator-induced genes by representational difference analysis: discoordinate regulation of the DN alpha/DO beta heterodimer.
Taxman DJ; Cressman DE; Ting JP
J Immunol; 2000 Aug; 165(3):1410-6. PubMed ID: 10903745
[TBL] [Abstract][Full Text] [Related]
17. RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency.
Durand B; Sperisen P; Emery P; Barras E; Zufferey M; Mach B; Reith W
EMBO J; 1997 Mar; 16(5):1045-55. PubMed ID: 9118943
[TBL] [Abstract][Full Text] [Related]
18. Correction of defective expression in MHC class II deficiency (bare lymphocyte syndrome) cells by retroviral transduction of CIITA.
Bradley MB; Fernandez JM; Ungers G; Diaz-Barrientos T; Steimle V; Mach B; O'Reilly R; Lee JS
J Immunol; 1997 Aug; 159(3):1086-95. PubMed ID: 9233601
[TBL] [Abstract][Full Text] [Related]
19. Introduction of exogenous class II trans-activator in MHC class II-deficient ABI fibroblasts results in incomplete rescue of MHC class II antigen expression.
Peijnenburg A; Gobin SJ; van Eggermond MC; Godthelp BC; van Graafeiland N; van den Elsen PJ
J Immunol; 1997 Sep; 159(6):2720-7. PubMed ID: 9300692
[TBL] [Abstract][Full Text] [Related]
20. Novel mutations in the RFXANK gene: RFX complex containing in-vitro-generated RFXANK mutant binds the promoter without transactivating MHC II.
Wiszniewski W; Fondaneche MC; Louise-Plence P; Prochnicka-Chalufour A; Selz F; Picard C; Le Deist F; Eliaou JF; Fischer A; Lisowska-Grospierre B
Immunogenetics; 2003 Feb; 54(11):747-55. PubMed ID: 12618906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
